Home › Upcoming votes › XBiotech Inc.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in XBiotech Inc.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For | — |
| 2 | RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Auditor |
Board | For | 97% support |
| 3 | ADVISORY VOTE ON THE EXECUTIVE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS Say on pay |
Board | For | 89% support |
From XBiotech Inc.’s Form 8-K, filed September 2, 2025, for the meeting held August 29, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: John Simard | — | — |
| Elect Director: Thomas Kündig | — | — |
| Elect Director: Craig Rademaker | — | — |
| Elect Director: Tevi D. Troy | — | — |
| Elect Director: David Soffer | — | — |
| 2. Ratification of the selection of Whitley Penn LLP as the Company's independent registered public accounting firm for the fiscal year endi | 97% | — |
| 3. Advisory Vote on Executive Compensation | 89% | — |
| 4. Approval of the Company's 2025 Equity Incentive Plan | 93% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.